VivoSim Labs, INC.
VIVS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001497253
In the last 90 days, VivoSim Labs, INC. insiders filed 1 open-market purchase and 0 sales; 25 institutions reported holding it in 13F filings for Q2 2026, worth $109.7K in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in VivoSim Labs, INC. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- −9 vs. Q4 2024
- Shares held
- 63.7K
- −144.1K (−69.3%) vs. Q4 2024Converted for a 1-for-12 split
- Total value
- $142.6K
- −$1.00M (−87.6%) vs. Q4 2024
- New holders
- 3
- 8 more added
- Sold out
- 12
- 8 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VIVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 25 | $109.7K |
| Q1 2026 | 24 | $140.0K |
| Q4 2025 | 27 | $189.3K |
| Q3 2025 | 29 | $644.4K |
| Q2 2025 | 26 | $189.0K |
| Q1 2025 | 23 | $142.6K |
| Q4 2024 | 32 | $1.15M |
| Q3 2024 | 31 | $1.24M |
| Q2 2024 | 34 | $1.77M |
| Q1 2024 | 34 | $911.7K |
| Q4 2023 | 36 | $932.1K |
| Q3 2023 | 34 | $894.3K |
| Q2 2023 | 36 | $1.35M |
| Q1 2023 | 39 | $1.76M |
| Q4 2022 | 42 | $2.64M |
| Q3 2022 | 43 | $4.07M |
| Q2 2022 | 44 | $3.43M |
| Q1 2022 | 39 | $7.42M |
| Q4 2021 | 48 | $8.23M |
| Q3 2021 | 43 | $14.9M |
| Q2 2021 | 51 | $21.4M |
| Q1 2021 | 46 | $23.1M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding VivoSim Labs, INC.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Prescott Group Capital Management, L.L.C. | 23,375 | $52.4K | 0.01% | 00.0% | UnchangedConverted for a 1-for-12 split |
| Vanguard Group Inc | 22,374 | $50.1K | 0.00% | +12,821+134.2% | AddedConverted for a 1-for-12 split |
| BlackRock, Inc. | 11,844 | $26.5K | 0.00% | 00.0% | UnchangedConverted for a 1-for-12 split |
| Morgan Stanley | 4,990 | $11.2K | 0.00% | +3,328+200.3% | AddedConverted for a 1-for-12 split |
| Allworth Financial LP | 208 | $425 | 0.00% | 00.0% | UnchangedConverted for a 1-for-12 split |
| Tower Research Capital LLC (TRC) | 179 | $401 | 0.00% | −569−76.1% | ReducedConverted for a 1-for-12 split |
| SBI Securities Co., Ltd. | 169 | $379 | 0.00% | +12+7.6% | AddedConverted for a 1-for-12 split |
| Wells Fargo & Company | 160 | $359 | 0.00% | +7+4.2% | AddedConverted for a 1-for-12 split |
| Albion Financial Group | 159 | $357 | 0.00% | 00.0% | UnchangedConverted for a 1-for-12 split |
| Advisor Group Holdings, Inc. | 133 | $293 | 0.00% | +8+6.8% | AddedConverted for a 1-for-12 split |
| UBS Group AG | 53 | $119 | 0.00% | +36+219.6% | AddedConverted for a 1-for-12 split |
| Bank of America Corp | 23 | $51 | 0.00% | −37−61.7% | ReducedConverted for a 1-for-12 split |
| Danske Bank A/S | 4 | $9 | 0.00% | +4 | New |
| JPMorgan Chase & Co | 3 | $7 | 0.00% | −0−10.0% | ReducedConverted for a 1-for-12 split |
| McIlrath & Eck, LLC | 2 | $4 | 0.00% | −1−31.4% | ReducedConverted for a 1-for-12 split |
| Golden State Wealth Management, LLC | 2 | $4 | 0.00% | −0−4.0% | ReducedConverted for a 1-for-12 split |
| Cullen/Frost Bankers, Inc. | 2 | $4 | 0.00% | +0+20.0% | AddedConverted for a 1-for-12 split |
| Federation des caisses Desjardins du Quebec | 2 | $4 | 0.00% | +2+700.0% | AddedConverted for a 1-for-12 split |
| Harbour Investments, Inc. | 1 | $2 | 0.00% | −0−7.7% | ReducedConverted for a 1-for-12 split |
| CIBC Private Wealth Group, LLC | 1 | $2 | 0.00% | +1 | New |
| CWM, LLC | 6 | $0 | 0.00% | −1−10.0% | ReducedConverted for a 1-for-12 split |
| TSFG, LLC | 2 | $0 | 0.00% | −0−4.0% | ReducedConverted for a 1-for-12 split |
| Royal Bank of Canada | 6 | $0 | 0.00% | +6 | New |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −136,554−100.0% | Sold outConverted for a 1-for-12 split |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −10,044−100.0% | Sold outConverted for a 1-for-12 split |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −3,299−100.0% | Sold outConverted for a 1-for-12 split |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −2,636−100.0% | Sold outConverted for a 1-for-12 split |
| State Street Corp | 0 | $0 | 0.00% | −2,319−100.0% | Sold outConverted for a 1-for-12 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −2,067−100.0% | Sold outConverted for a 1-for-12 split |
| Wedbush Securities Inc | 0 | $0 | 0.00% | −1,567−100.0% | Sold outConverted for a 1-for-12 split |
| XTX Topco Ltd | 0 | $0 | 0.00% | −1,196−100.0% | Sold outConverted for a 1-for-12 split |
| Coppell Advisory Solutions LLC | 0 | $0 | 0.00% | −10−100.0% | Sold outConverted for a 1-for-12 split |
| Glen Eagle Advisors, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold outConverted for a 1-for-12 split |
| HHM Wealth Advisors, LLC | 0 | $0 | 0.00% | −0−100.0% | Sold outConverted for a 1-for-12 split |
| Ameriflex Group, Inc. | 0 | $0 | 0.00% | −0−100.0% | Sold outConverted for a 1-for-12 split |